×
Labcorp Inventory 2010-2024 | LH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Labcorp inventory for the quarter ending December 31, 2024 was
$0.493B
, a
3.92% increase
year-over-year.
Labcorp inventory for 2024 was
$0.493B
, a
3.92% increase
from 2023.
Labcorp inventory for 2023 was
$0.475B
, a
0.85% increase
from 2022.
Labcorp inventory for 2022 was
$0.471B
, a
17.24% increase
from 2021.
View More
Labcorp Inventory 2010-2024 | LH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Labcorp inventory for 2024 was
$0.493B
, a
3.92% increase
from 2023.
Labcorp inventory for 2023 was
$0.475B
, a
0.85% increase
from 2022.
Labcorp inventory for 2022 was
$0.471B
, a
17.24% increase
from 2021.
Related Stocks
Company Name
Market
Cap
McKesson (MCK)
$87.4B
Becton Dickinson (BDX)
$57.1B
Cardinal Health (CAH)
$32.5B
Straumann Holding AG (SAUHY)
$18.7B
Cooper (COO)
$15.9B
West Pharmaceutical Services (WST)
$14.6B
Align Technology (ALGN)
$12.5B
Henry Schein (HSIC)
$7.9B
Merit Medical Systems (MMSI)
$5.4B
Patterson (PDCO)
$2.8B
DENTSPLY SIRONA (XRAY)
$2.6B
CONMED (CNMD)
$1.5B
STAAR Surgical (STAA)
$833M
Pro-Dex (PDEX)
$198M
Lifevantage (LFVN)
$169M